The {pharmaceutical market is currently exploring alternative treatment approaches for obesity , and the emergence of semaglutide 10mg doses represents a significant change. Clinicians are now assess the likely benefits and drawbacks associated with this increased strength product, especially in contrast with existing standard semaglutide products